6. Real options and put–call parity (S23.2) Redo the example in Figure 23.2, assuming that the real option is a put option allowing the company to abandon the R&D program if commercial prospects are sufficiently poor at year 2. Use put–call parity. The NPV of the drug at date 0 should again be +$7.7 million.